Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LaMB maintenance lapatinib versus placebo in advanced or metastatic bladder cancer
ISRCTN35418671Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in transitional cell carcinoma (TCC) and bladder cancer comparing Lapatinib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Started Oct 2008; status: completed.
02
Drugs
lapatinib
03
Conditions
transitional cell carcinoma (TCC)bladder cancer
Beyond the preview
Go deeper on ISRCTN35418671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN35418671.